These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8393963)

  • 41. P63 differentiates subtypes of nonsmall cell carcinomas of lung in cytologic samples: implications in treatment selection.
    Jorda M; Gomez-Fernandez C; Garcia M; Mousavi F; Walker G; Mejias A; Fernandez-Castro G; Ganjei-Azar P
    Cancer; 2009 Feb; 117(1):46-50. PubMed ID: 19347829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.
    Kren L; Brazdil J; Hermanova M; Goncharuk VN; Kallakury BV; Kaur P; Ross JS
    Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):44-9. PubMed ID: 15163019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bcl-2 expression in non-small cell lung cancers: higher frequency of expression in squamous cell carcinomas with earlier pT status.
    Dosaka-Akita H; Katabami M; Hommura H; Fujioka Y; Katoh H; Kawakami Y
    Oncology; 1999 Apr; 56(3):259-64. PubMed ID: 10202283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apoptosis and bcl-2 expression as predictors of survival in radiation-treated non-small-cell lung cancer.
    Hwang JH; Lim SC; Kim YC; Park KO; Ahn SJ; Chung WK
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):13-8. PubMed ID: 11316541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.
    Ichimura E; Maeshima A; Nakajima T; Nakamura T
    Jpn J Cancer Res; 1996 Oct; 87(10):1063-9. PubMed ID: 8957065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases.
    Anton RC; Brown RW; Younes M; Gondo MM; Stephenson MA; Cagle PT
    Hum Pathol; 1997 Sep; 28(9):1079-82. PubMed ID: 9308733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients.
    Fleming MV; Guinee DG; Chu WS; Freedman AN; Caporaso NE; Bennett WP; Colby TV; Tazelaar H; Abbondanzo SL; Jett J; Pairolero P; Trastek V; Liotta LA; Harris CC; Travis WD
    Hum Pathol; 1998 Jan; 29(1):60-4. PubMed ID: 9445135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium.
    Pankova OV; Denisov EV; Ponomaryova AA; Gerashchenko TS; Tuzikov SA; Perelmuter VM
    Tumour Biol; 2016 Mar; 37(3):3599-607. PubMed ID: 26456960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer.
    Silvestrini R; Costa A; Lequaglie C; Mochen C; Veneroni S; Leutner M; Ravasi G
    Virchows Arch; 1998 May; 432(5):441-4. PubMed ID: 9645443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bcl-2 as a prognostic factor for survival in small-cell lung cancer.
    Ilievska Poposka B; Smickova S; Jovanovska Crvenkovska S; Zafirovska Ivanovska B; Stefanovski T; Petrusevska G
    Prilozi; 2008 Dec; 29(2):281-93. PubMed ID: 19259053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small cell carcinomas of the lung express the Bcl-2 protein.
    Ben-Ezra JM; Kornstein MJ; Grimes MM; Krystal G
    Am J Pathol; 1994 Nov; 145(5):1036-40. PubMed ID: 7977636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal-cell carcinoma.
    Cerroni L; Kerl H
    J Cutan Pathol; 1994 Oct; 21(5):398-403. PubMed ID: 7868750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome.
    Uehara T; Kuwashima Y; Izumo T; Kishi K; Shiromizu K; Matsuzawa M
    Eur J Gynaecol Oncol; 1995; 16(6):453-60. PubMed ID: 8536760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiation and programmed cell death-related intermediate biomarkers for the development of non-small cell lung cancer: a pilot study.
    Zhang H; Yousem SA; Franklin WA; Elder E; Landreneau R; Ferson P; Keenan R; Whiteside T; Levitt ML
    Hum Pathol; 1998 Sep; 29(9):965-71. PubMed ID: 9744313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuclear DNA in histologic sections from squamous-cell carcinoma and adenocarcinoma of the lung.
    Nishimiya K; Auer GU; Erhardt K; Wiman LG; Kato H; Hayata Y
    Anal Quant Cytol Histol; 1985 Jun; 7(2):153-8. PubMed ID: 3896254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer.
    Verhaegh ME; Sanders CJ; Arends JW; Neumann HA
    Br J Dermatol; 1995 May; 132(5):740-4. PubMed ID: 7772478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival in small cell lung carcinoma is independent of Bcl-2 expression.
    Maitra A; Amirkhan RH; Saboorian MH; Frawley WH; Ashfaq R
    Hum Pathol; 1999 Jun; 30(6):712-7. PubMed ID: 10374782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of paraneoplastic rheumatic syndrome in lung cancer patients on tumor expression of BCL-2].
    Lysenko SA
    Vopr Onkol; 2013; 59(6):731-4. PubMed ID: 24624782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of Transcription Factor PU.1 in Stromal Cells as a Prognostic Marker in Non-Small Cell Lung Cancer.
    Kovaleva OV; Rashidova MA; Samoilova DV; Podlesnaya PA; Mochalnikova VV; Gratchev AN
    Bull Exp Biol Med; 2021 Feb; 170(4):489-492. PubMed ID: 33713236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bcl-2 oncoprotein expression is increased especially in the portion of small cell carcinoma within the combined type of small cell lung cancer.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
    Tumour Biol; 1996; 17(6):341-4. PubMed ID: 8938949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.